Copyright
©The Author(s) 2017.
World J Hepatol. Dec 28, 2017; 9(36): 1378-1384
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1378
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1378
WBC | 5800/μL | ALP | 228 U/L | PIVKA-II | 18 mAU/mL |
RBC | 432 × 104/μL | γ-GTP | 65 U/L | AFP | 3 ng/mL |
Hb | 13.0 g/dL | ChE | 280 IU/L | AFP-L3 | 0.5% |
Ht | 38% | BUN | 14.5 mg/dL | CEA | 1.2 ng/mL |
Plt | 22.6 × 104/μL | Cr | 0.54 mg/dL | CA 19-9 | 7 U/mL |
PT | 77.3% | T-Chol | 203 mg/dL | ANA | × 40 |
PT-INR | 1.04 | TG | 77 mg/dL | AMA | × 640 |
TP | 7.9 g/dL | ICG-R15 | 8.3% | AMA-M2 | 158 Index |
Alb | 4.2 g/dL | Glucose | 109 mg/dL | HBs Ag | (-) |
TBil | 0.5 mg/dL | CRP | 0.2 mg/dL | HBs Ab | (-) |
AST | 19 U/L | IgG | 1760 mg/dL | HBc Ab | (-) |
ALT | 14 U/L | IgM | 305 mg/dL | HCV Ab | (-) |
LDH | 183 U/L |
WBC | 3600/μL | AST | 29 U/L | PIVKA-II | 28 mAU/mL |
RBC | 397 × 104/μL | ALT | 18 U/L | AFP | 5 ng/mL |
Hb | 12.0 g/dL | LDH | 186 U/L | AFP-L3 | 11.7% |
Ht | 35.9% | ALP | 300 U/L | CEA | 1.0 ng/mL |
Plt | 22.3 × 104/μL | γ-GTP | 79 U/L | CA 19-9 | 29 U/mL |
PT | 77.3% | ChE | 211 IU/L | ICG-R15 | 7.4% |
PT-INR | 1.12 | BUN | 16.1 mg/dL | Glucose | 138 mg/dL |
TP | 7.3 g/dL | Cr | 0.6 mg/dL | CRP | 0.2 mg/dL |
Alb | 3.8 g/dL | T-Bil | 0.4 mg/dL |
- Citation: Ide R, Oshita A, Nishisaka T, Nakahara H, Aimitsu S, Itamoto T. Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1378-1384
- URL: https://www.wjgnet.com/1948-5182/full/v9/i36/1378.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i36.1378